Labyrinthopeptin A1 and A2 efficiently inhibit cell entry of hRSV isolates

S. Haid (Hannover, Germany)

Source: International Congress 2017 – From microbiology to clinical work
Session: From microbiology to clinical work
Session type: Thematic Poster
Number: 4124
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Haid (Hannover, Germany). Labyrinthopeptin A1 and A2 efficiently inhibit cell entry of hRSV isolates. 4124

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: Effects of a single treatment with PC786, a novel inhibitor of respiratory syncytial virus replication, on viral load and biomarkers in fully differentiated human bronchial epithelial cells
Source: International Congress 2016 – Translational research in respiratory infections
Year: 2016


Rhinovirus infection of human macrophages causes TNF-α production through an NF-κ B dependent mechanism
Source: Eur Respir J 2004; 24: Suppl. 48, 483s
Year: 2004

M2 macrophages produce less type I and III IFNs upon human rhinovirus (HRV) infection and have a higher viral load than M1 macrophages
Source: Annual Congress 2011 - Macrophages and neutrophils in chronic lung disease
Year: 2011


Potential inhibitors of respiratory syncytial virus (RSV) selected from a phage displayed random peptide library
Source: Eur Respir J 2002; 20: Suppl. 38, 158s
Year: 2002

Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020


Glycosylation studies of G-protein of BA genotype of group B human respiratory syncytial virus in mammalian cells
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015

Human rhinovirus 16 infection of human macrophages impairs their clearance ability by perturbing phagosome maturation
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018



Rhinovirus up-regulates toll-like receptor 3 on bronchial epithelial cells and is dependent on viral replication
Source: Annual Congress 2004 - Mechanisms and treatment of virus induced asthma exacerbations
Year: 2004


A novel mechanism for upregulation of β2-integrin and adhesion of eosinophils by secretory group V phospholipase A2 independent of cytosolic phospholipase A2 activation
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005


Effects of respiratory syncytial virus and adenovirus infection in cytokine expression and nuclear factor-κB activation human bronchial epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 192s
Year: 2006

Lymphocytes mediate the anti-apoptotic effect of respiratory syncytial virus on human neutrophils
Source: Annual Congress 2007 - Bronchiolitis - genetics and immunity
Year: 2007


shRNAs significantly reduce the replication of RSV in vitro
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011

Rhinovirus infection differentially modulates MHC class I-related chain (MIC) A and B molecules in human respiratory epithelial cells
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009


Influenza infection of monocyte-macrophages is insensitive to inhibition by NH4Cl
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009


Proteomics of fully differentiated bronchial epithelial cells derived from COPD or control shows no significant differences in susceptibility or response to influenza virus infection
Source: Virtual Congress 2021 – Early manifestations of chronic respiratory disease: zooming in at the epithelial barrier
Year: 2021



Acutely lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016

A549 and monocyte derived dendritic cells (MODCS) Transwell co-culture: respiratory syncytial virus (RSV) infection of the apical and basolateral surfaces
Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood
Year: 2009

Cell surface expression of α2,3 and α2,6 sialic acids does not determine susceptibility of human cell lines to influenza infection
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009


The NS1A binding protein in alveolar epithelial cells as centerpiece of Influenza virus A lung injury mechanism mediated via AhR/Arnt signaling pathway
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017

Adeno-associated virus serotype 5 efficiently transduces human respiratory epithelium
Source: Eur Respir J 2001; 18: Suppl. 33, 407s
Year: 2001